“The Future-Proof Portfolio for Young Investors:: SELLAS Life Sciences Group, Inc., (NASDAQ: SLS)”
October 18, 2019
“… The EPS of SELLAS Life Sciences Group, Inc., SLS is strolling at -1.49, measuring its EPS growth this year at 69.8%. As a result, the company has an EPS growth of 64.3% for the approaching year…
Target Price informs the investors, a stock survey at which a trader is willing to buy or sell a stock. Target pricing at which a trader projects that a buyer will buy a product. Analyst’s mean target price for the company is $1.75…”
Make no mistake this is a penny stock you want to keep your eye on.